Direct oral anticoagulants
163 results
101 - 163Anticoagulant therapy for 6 weeks is noninferior to 3 months for provoked VTE in patients younger than 21 years (Kids-DOTT)
Mitral regurgitation
Warfarin therapy
Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Oral anticoagulation for prolonging survival in patients with cancer
Guidelines for the perioperative management of anticoagulants and antiplatelet agents (ACCP)
Aortic stenosis
ACCP guidelines for antithrombotics in atrial fibrillation
Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery
Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Deep vein thrombosis
Anticoagulation for the long‐term treatment of venous thromboembolism in people with cancer
Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Pentasaccharides for the prevention of venous thromboembolism: Cochrane systematic review
Older patients with atrial fibrillation treated with DOACs have fewer strokes and systemic emboli than those treated with vitamin K antagonists
Benefits and harms with oral anticoagulation for atrial fibrillation in patients with history of intracranial hemorrhage (COCROACH)
Superficial venous thrombophlebitis
Nephrotic syndrome
Rivaroxaban is noninferior to warfarin for valvular atrial fibrillation; also associated with fewer strokes
Interrupted versus uninterrupted anticoagulation for cardiac rhythm management device insertion
Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia
Heart valve operation: patient follow-up and complications
Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolism
Edoxaban as effective as LMWH for treatment of cancer-associated VTE
Interrupted versus uninterrupted anticoagulation therapy for catheter ablation in adults with arrhythmias
Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Greater risk of serious bleeding with diltiazem vs metoprolol in adults with atrial fibrillation using apixaban or rivaroxaban
Abelacimab has fewer bleeds than rivaroxaban, but study has several important biases
Primary prophylaxis for venous thromboembolism in patients undergoing cardiac or thoracic surgery
Vitamin K for improved anticoagulation control in patients receiving warfarin
Extended rivaroxaban prophylaxis following a medical inpatient stay does not provide a net benefit (MARINER)
Warfarin provides greater net benefit than rivaroxaban for patients with atrial fibrillation and rheumatic heart disease
ACG guideline on managing acute lower gastrointestinal bleeding
Optimal treatment of acute venous thromboembolism
Heparin for the prevention of venous thromboembolism in acutely ill medical patients (excluding stroke and myocardial infarction): Cochrane systematic review
Assessment and treatment of a patient with bleeding diathesis
Antithrombotic therapy for ambulatory patients with multiple myeloma receiving immunomodulatory agents
Updated American College of Chest Physicians guideline on antithrombotic therapy for venous thromboembolism
Prevention of venous thromboembolism
Systemic lupus erythematosus (SLE)
Electrical cardioversion
Continuous intravenous perioperative lidocaine infusion for postoperative pain and recovery in adults: Cochrane systematic review
Home versus in‐patient treatment for deep vein thrombosis
Anticoagulation for the long term treatment of venous thromboembolism in patients with cancer
Pharmacological interventions for preventing venous thromboembolism in people undergoing bariatric surgery
Lumbar puncture
Management of acute atrial fibrillation
Acute coronary syndrome
Cerebral infarction (ischaemic stroke)
COVID-19 and other coronavirus infections